<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский вестник Юга России</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Herald of the South of Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">mvjr-1258</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW</subject></subj-group></article-categories><title-group><article-title>Взаимодействие кишечной микрофлоры с Тoll-подобными рецепторами в норме и патологии</article-title><trans-title-group xml:lang="en"><trans-title>Interaction of intestinal microflora with Toll-like receptors in health and pathology</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бондаренко</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bondarenko</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>123098, г. Москва, ул. Гамалеи, 18</p></bio><bio xml:lang="en"><p>18 Gamaleya st., Moscow, 123098</p></bio><email xlink:type="simple">bvmc@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лиходед</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Likhoded</surname><given-names>V. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>123098, г. Москва, ул. Гамалеи, 18</p></bio><bio xml:lang="en"><p>18 Gamaleya st., Moscow, 123098</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ эпидемиологии и микробиологии им. Н. Ф. Гамалеи РАМН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Gamaleya Institute of Epidemiology and Microbiology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>30</day><month>03</month><year>2010</year></pub-date><volume>0</volume><issue>1</issue><fpage>4</fpage><lpage>8</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бондаренко В.М., Лиходед В.Г., 2010</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="ru">Бондаренко В.М., Лиходед В.Г.</copyright-holder><copyright-holder xml:lang="en">Bondarenko V.M., Likhoded V.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/1258">https://www.medicalherald.ru/jour/article/view/1258</self-uri><abstract><p>Рассмотрены данные о взаимодействии нормальной кишечной микрофлоры с Toll-подобными рецепторами (TLR) макроорганизма. Совокупность имеющихся сведений показывает, что TLR распознают лиганды (поверхностные структуры и нуклеиновые кислоты) нормальной микрофлоры кишечника в физиологических условиях и такое взаимодействие необходимо для поддержания гомеостаза кишечника. Лиганды нормофлоры стимулируют репарацию повреждений кишечного эпителия и выживаемость животных, обработанных декстран-сульфатом натрия или резерпином. Взаимодействие лигандов нормофлоры с TLR ведет путем передачи сигнала к активации транскрипционного фактора NF-kB и к экспрессии провоспалительных, противовоспалительных цитокинов и протективных факторов. То, как разовьются дальнейшие события и будет формироваться хронический воспалительный процесс, зависит от многих факторов, в том числе от дозы воздействия и от активности воздействующего фактора. Одним из наиболее активных лигандов кишечной микрофлоры является ЛПС (эндотоксин) грамотрицательных бактерий.</p></abstract><trans-abstract xml:lang="en"><p>Toll-like receptors (TLR) can interact with intestinal microflora under physiological steady-state conditions. This interaction is required for intestinal homeostasis. Activation of TLRs by ligands of commensal microflora is required for the protection against gut injury and associated mortality. The normoflora ligands induce the expression of proinflammation and anti-inflammation cytokines. The more active normoflora ligand is lipopolysaccharide (LPS).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>TLR</kwd><kwd>нормофлора</kwd><kwd>ЛПС</kwd><kwd>эндотоксин</kwd><kwd>цитокины</kwd></kwd-group><kwd-group xml:lang="en"><kwd>TLR</kwd><kwd>normoflora</kwd><kwd>LPS</kwd><kwd>endotoxin</kwd><kwd>cytokines</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бондаренко В.М., Лиходед В.Г. Идеи И.И.Мечникова и современная микроэкология кишечника человека //Микробиология. – 2008. – № 5. – С. 23–29.</mixed-citation><mixed-citation xml:lang="en">Бондаренко В.М., Лиходед В.Г. Идеи И.И.Мечникова и современная микроэкология кишечника человека //Микробиология. – 2008. – № 5. – С. 23–29.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ковальчук Л.В., Хорева Р.В., Варивода А.С. Врожденные компоненты иммунитета: Toll-подобные рецепторы в норме и при иммунопатологии //Микробиология. – 2005. – № 4. – С. 96–104.</mixed-citation><mixed-citation xml:lang="en">Ковальчук Л.В., Хорева Р.В., Варивода А.С. Врожденные компоненты иммунитета: Toll-подобные рецепторы в норме и при иммунопатологии //Микробиология. – 2005. – № 4. – С. 96–104.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Лебедев К.А., Понякина И.Д. Иммунофизиология эпителиальных клеток и образраспознающие рецепторы //Физиология человека. – 2006. – № 32(2). – С. 97–109.</mixed-citation><mixed-citation xml:lang="en">Лебедев К.А., Понякина И.Д. Иммунофизиология эпителиальных клеток и образраспознающие рецепторы //Физиология человека. – 2006. – № 32(2). – С. 97–109.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Фрейдлин И.С. Современные представления о фагоцитарной теории //Микробиология. – 2008. – № 5. – С. 4–10.</mixed-citation><mixed-citation xml:lang="en">Фрейдлин И.С. Современные представления о фагоцитарной теории //Микробиология. – 2008. – № 5. – С. 4–10.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ковальчук Л.В. Учение о воспалении в свете новых данных: развитие идей И.И.Мечникова //Микробиология. – 2008. – № 5. – С. 10–15.</mixed-citation><mixed-citation xml:lang="en">Ковальчук Л.В. Учение о воспалении в свете новых данных: развитие идей И.И.Мечникова //Микробиология. – 2008. – № 5. – С. 10–15.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology //Cold Spring Нarbor Symposium Quant Biology. – 1989. – № 54. – P. 1–13.</mixed-citation><mixed-citation xml:lang="en">Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology //Cold Spring Нarbor Symposium Quant Biology. – 1989. – № 54. – P. 1–13.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Johnston S.D., Nusslein-Volhard C. The origin of pattеrn and polarity in the Drosophila embrio //Cell. – 1992. – № 68 (2). – P. 201–207.</mixed-citation><mixed-citation xml:lang="en">Johnston S.D., Nusslein-Volhard C. The origin of pattеrn and polarity in the Drosophila embrio //Cell. – 1992. – № 68 (2). – P. 201–207.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mc Greal E.P., Miller J.L., Gordon S. Ligand recognition by antigen-presenting cell C-type lectin receptors //Curr. Opin. Immunol. – 2005. – № 17(1). – P. 18–24.</mixed-citation><mixed-citation xml:lang="en">Mc Greal E.P., Miller J.L., Gordon S. Ligand recognition by antigen-presenting cell C-type lectin receptors //Curr. Opin. Immunol. – 2005. – № 17(1). – P. 18–24.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Medzhitov R. Toll-like receptors and innate immunity //Nat. Rev. Immunol. – 2001. – № 1(2). – P. 143–145.</mixed-citation><mixed-citation xml:lang="en">Medzhitov R. Toll-like receptors and innate immunity //Nat. Rev. Immunol. – 2001. – № 1(2). – P. 143–145.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Armant M.A., Matthew E.J. Toll-like receptors: a family pattern-recognition receptors in mammals //Genome biol. – 2002. – № 3(1). – P. 3011–3020.</mixed-citation><mixed-citation xml:lang="en">Armant M.A., Matthew E.J. Toll-like receptors: a family pattern-recognition receptors in mammals //Genome biol. – 2002. – № 3(1). – P. 3011–3020.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Underhill D.M. Toll-like receptors and microbes take aim at each other //Curr. Opin. Immunol. – 2004. – № 16. – P. 483–487.</mixed-citation><mixed-citation xml:lang="en">Underhill D.M. Toll-like receptors and microbes take aim at each other //Curr. Opin. Immunol. – 2004. – № 16. – P. 483–487.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors //Sem.Immunol. – 2007. – № 19. – P. 3–10.</mixed-citation><mixed-citation xml:lang="en">Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors //Sem.Immunol. – 2007. – № 19. – P. 3–10.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Бондаренко В.М., Мацулевич Т.В. Дисбактериоз кишечника как клинико-лабораторный синдром: современное состояние проблемы. – М.: ГЭОТАР-Медиа, 2007. – 304 с.</mixed-citation><mixed-citation xml:lang="en">Бондаренко В.М., Мацулевич Т.В. Дисбактериоз кишечника как клинико-лабораторный синдром: современное состояние проблемы. – М.: ГЭОТАР-Медиа, 2007. – 304 с.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Akira S. Toll-like receptor signaling //J.Biol.Chem. – 2003. – № 278. – P. 38105–38108.</mixed-citation><mixed-citation xml:lang="en">Akira S. Toll-like receptor signaling //J.Biol.Chem. – 2003. – № 278. – P. 38105–38108.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Лебедев К.А., Понякина И.Д. Иммунофизиология эндогенных инфекций (определяющая роль образраспознающих рецепторов) //Аллергол. иммунол. – 2006. – № 7(2). – С. 207–213.</mixed-citation><mixed-citation xml:lang="en">Лебедев К.А., Понякина И.Д. Иммунофизиология эндогенных инфекций (определяющая роль образраспознающих рецепторов) //Аллергол. иммунол. – 2006. – № 7(2). – С. 207–213.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Melmed G., Thomas L.S., Lee N. et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut //J. Immunol. – 2003. – № 170(3). – P. 1405–1415.</mixed-citation><mixed-citation xml:lang="en">Melmed G., Thomas L.S., Lee N. et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut //J. Immunol. – 2003. – № 170(3). – P. 1405–1415.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen N., Morriset J., Emilie D. Induction of tolerance by porphyromonas gingivalis on APCs //J.Dent.Res. – 2004. – № 83(5). – P. 429–433.</mixed-citation><mixed-citation xml:lang="en">Cohen N., Morriset J., Emilie D. Induction of tolerance by porphyromonas gingivalis on APCs //J.Dent.Res. – 2004. – № 83(5). – P. 429–433.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Pickard K.M., Bremner A.N., Gordon J.N. et al. Microbial-gut interactions in health and disease. Immune responses //Вest Pract. Res. Clin. Gastrоenterol. – 2004. – № 18(2). – P. 271–285.</mixed-citation><mixed-citation xml:lang="en">Pickard K.M., Bremner A.N., Gordon J.N. et al. Microbial-gut interactions in health and disease. Immune responses //Вest Pract. Res. Clin. Gastrоenterol. – 2004. – № 18(2). – P. 271–285.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Backhed F., Normark K.S., Schweda E.K. et al. Structural requirements for TLR4-mediated LPS signaling: a biological role for LPS modification //Microbes Infect. – 2003. – № 5(12). – P. 1057–1063.</mixed-citation><mixed-citation xml:lang="en">Backhed F., Normark K.S., Schweda E.K. et al. Structural requirements for TLR4-mediated LPS signaling: a biological role for LPS modification //Microbes Infect. – 2003. – № 5(12). – P. 1057–1063.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Perdigon G., Galdeano C.M., Valdez J.C., Medici M. Interaction of lactic acid bacteria with gut immune system //Eur. J. Clin. Nutr. - 2002. – № 56 (Suppl.4). – P. 21–26.</mixed-citation><mixed-citation xml:lang="en">Perdigon G., Galdeano C.M., Valdez J.C., Medici M. Interaction of lactic acid bacteria with gut immune system //Eur. J. Clin. Nutr. - 2002. – № 56 (Suppl.4). – P. 21–26.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Galdeano C.M., Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity //Clin, Vaccine Immunol. – 2006. – № 13(2). – P. 219–226.</mixed-citation><mixed-citation xml:lang="en">Galdeano C.M., Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity //Clin, Vaccine Immunol. – 2006. – № 13(2). – P. 219–226.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Vinderola G., Matar C., Perdigon G. Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors //Clin. Diagn. Lab. Immunol. – 2005. – № 12(9). – P. 1075–1084.</mixed-citation><mixed-citation xml:lang="en">Vinderola G., Matar C., Perdigon G. Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors //Clin. Diagn. Lab. Immunol. – 2005. – № 12(9). – P. 1075–1084.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Rakoff – Wahoum S., Paglino J., Esmali Varzaneh F. et al. Recognition of cоmmensal microflora by toll-like receptors is recquired for intestinal homeostasis // Cell. – 2004. – № 118(2). – P. 229–241.</mixed-citation><mixed-citation xml:lang="en">Rakoff – Wahoum S., Paglino J., Esmali Varzaneh F. et al. Recognition of cоmmensal microflora by toll-like receptors is recquired for intestinal homeostasis // Cell. – 2004. – № 118(2). – P. 229–241.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Takeda K., Kaisho T., Akira S. Toll-like receptors// Annu. Rev. Immunol. – 2003. – № 21. – P. 335–376.</mixed-citation><mixed-citation xml:lang="en">Takeda K., Kaisho T., Akira S. Toll-like receptors// Annu. Rev. Immunol. – 2003. – № 21. – P. 335–376.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Rachmilevitz D., Katakura K., Karmeli F. et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effect of probiotics in murine experimental colitis// Gastroenterol. – 2004. – № 126(2). – P. 520–528.</mixed-citation><mixed-citation xml:lang="en">Rachmilevitz D., Katakura K., Karmeli F. et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effect of probiotics in murine experimental colitis// Gastroenterol. – 2004. – № 126(2). – P. 520–528.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Бактериальные пробиотики: биотехнология, клиника, алгоритмы выбора / Петров Л.Н., Вербицкая Н.Б., Добрица В.П. и др. – СПб.: Гос.НИИ ОЧБ, 2008. – 136 с.</mixed-citation><mixed-citation xml:lang="en">Бактериальные пробиотики: биотехнология, клиника, алгоритмы выбора / Петров Л.Н., Вербицкая Н.Б., Добрица В.П. и др. – СПб.: Гос.НИИ ОЧБ, 2008. – 136 с.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Лиходед В.Г., Бондаренко В.М. Антиэндотоксиновый иммунитет в регуляции численности эшерихиозной микрофлоры кишечника. – М.: Медицина, 2007. – 216 с.</mixed-citation><mixed-citation xml:lang="en">Лиходед В.Г., Бондаренко В.М. Антиэндотоксиновый иммунитет в регуляции численности эшерихиозной микрофлоры кишечника. – М.: Медицина, 2007. – 216 с.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Лиходед В.Г., Мартынова В.Р. Роль Chlamydia pneumoniae в этиологии атеросклероза //Микробиология. – 2000. – № 4 (прилож.). – С. 117–121.</mixed-citation><mixed-citation xml:lang="en">Лиходед В.Г., Мартынова В.Р. Роль Chlamydia pneumoniae в этиологии атеросклероза //Микробиология. – 2000. – № 4 (прилож.). – С. 117–121.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ieven M.M., Hoymans V.Y. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence // J.Clin. Microbiol. – 2005. – № 43(1). – P. 19–24.</mixed-citation><mixed-citation xml:lang="en">Ieven M.M., Hoymans V.Y. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence // J.Clin. Microbiol. – 2005. – № 43(1). – P. 19–24.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Конев Ю.В. Системная эндотоксинемия и клинико-патогенетические особенности течения атеросклероза и ишемической болезни сердца в пожилом и старческом возрасте: Автореф. дис. докт.мед.наук. – М., 1997. – 43 с.</mixed-citation><mixed-citation xml:lang="en">Конев Ю.В. Системная эндотоксинемия и клинико-патогенетические особенности течения атеросклероза и ишемической болезни сердца в пожилом и старческом возрасте: Автореф. дис. докт.мед.наук. – М., 1997. – 43 с.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Чижиков Н.В., Лиходед В.Г., Светухин А.М., Яковлев М.Ю. Эндотоксин кишечной микрофлоры в клинике и патогенезе хронической ишемии нижних конечностей. – Пенза, 2002. – 169 с.</mixed-citation><mixed-citation xml:lang="en">Чижиков Н.В., Лиходед В.Г., Светухин А.М., Яковлев М.Ю. Эндотоксин кишечной микрофлоры в клинике и патогенезе хронической ишемии нижних конечностей. – Пенза, 2002. – 169 с.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Wiederman C. J., Kieshl S., Dunzendorfer S. et al. Endotoxemia and atherosclerosis //J. Endotox. Res. – 2000. – № 6(2). – P. 86.</mixed-citation><mixed-citation xml:lang="en">Wiederman C. J., Kieshl S., Dunzendorfer S. et al. Endotoxemia and atherosclerosis //J. Endotox. Res. – 2000. – № 6(2). – P. 86.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Лиходед В.Г., Яковлев М.Ю. Роль эндотоксина кишечной микрофлоры в патогенезе атеросклероза //Микробиология. – 2001. – № 6. – С. 105-109.</mixed-citation><mixed-citation xml:lang="en">Лиходед В.Г., Яковлев М.Ю. Роль эндотоксина кишечной микрофлоры в патогенезе атеросклероза //Микробиология. – 2001. – № 6. – С. 105-109.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Erridge C., Stewart J., Poxton I.R. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit lipopolysaccharide signaling //J.Exp.Med. – 2003. – № 197. – P. 1787–1791.</mixed-citation><mixed-citation xml:lang="en">Erridge C., Stewart J., Poxton I.R. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit lipopolysaccharide signaling //J.Exp.Med. – 2003. – № 197. – P. 1787–1791.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Сook D.N., Pisetsky D,S,, Schwartz D.A. Toll-like receptors in the pathogenesis of human disease //Nature Immunol. – 2004. – № 5(10). – P. 975–979.</mixed-citation><mixed-citation xml:lang="en">Сook D.N., Pisetsky D,S,, Schwartz D.A. Toll-like receptors in the pathogenesis of human disease //Nature Immunol. – 2004. – № 5(10). – P. 975–979.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Fink M.P., Mythen M.G. The role of gut-derived endotoxin in the pathogenesis of multiple organ dysfunction. Endotoxin in health and disease. Brade et al. ed. – N.Y.Basel, 1999. – P. 854–864.</mixed-citation><mixed-citation xml:lang="en">Fink M.P., Mythen M.G. The role of gut-derived endotoxin in the pathogenesis of multiple organ dysfunction. Endotoxin in health and disease. Brade et al. ed. – N.Y.Basel, 1999. – P. 854–864.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Li Liwu. Regulation of innate immunity signaling and its connection with human diseases. Current drug targets //Inflamm. Allergy – 2004. – № 3. – P. 81–86.</mixed-citation><mixed-citation xml:lang="en">Li Liwu. Regulation of innate immunity signaling and its connection with human diseases. Current drug targets //Inflamm. Allergy – 2004. – № 3. – P. 81–86.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Ulevitch R.J. Therapeutics targeting and innate immune system // Nature Rev. Immunol. – 2002. – № 4. – P. 512–520.</mixed-citation><mixed-citation xml:lang="en">Ulevitch R.J. Therapeutics targeting and innate immune system // Nature Rev. Immunol. – 2002. – № 4. – P. 512–520.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Wallin R.P., Lundquist A., More S.H. et al. Heat-shock proteins as activators innate immune system //Trends Immunol. – 2002. – № 23. – P. 130–135.</mixed-citation><mixed-citation xml:lang="en">Wallin R.P., Lundquist A., More S.H. et al. Heat-shock proteins as activators innate immune system //Trends Immunol. – 2002. – № 23. – P. 130–135.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Tsan Min-fu, Gao B. Endogenous ligands of Toll-like receptors // J. Leuk. Biol. – 2004. – № 76. – P. 514–519.</mixed-citation><mixed-citation xml:lang="en">Tsan Min-fu, Gao B. Endogenous ligands of Toll-like receptors // J. Leuk. Biol. – 2004. – № 76. – P. 514–519.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Satoh M., Shimoda Y., Akatsu T., et al. Elevated circulating levels of heat shock protein 70 are related to systemic inflammation reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction //Eur. Soc. Cardiol. – 2006. – № 8. – P. 810– 815.</mixed-citation><mixed-citation xml:lang="en">Satoh M., Shimoda Y., Akatsu T., et al. Elevated circulating levels of heat shock protein 70 are related to systemic inflammation reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction //Eur. Soc. Cardiol. – 2006. – № 8. – P. 810– 815.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Aukrust P., Gullestad L., Ueland T. et al. Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapetic implications //Annab. Med. – 2005. - № 37. – P. 74–85.</mixed-citation><mixed-citation xml:lang="en">Aukrust P., Gullestad L., Ueland T. et al. Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapetic implications //Annab. Med. – 2005. - № 37. – P. 74–85.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Ковальчук Л.В., Хорева М.В., Варивода А.С. и др. Роль рецепторов врожденного иммунитета в развитии острого инфаркта миокарда //Микробиология. – 2008. – № 4. – С. 64–68.</mixed-citation><mixed-citation xml:lang="en">Ковальчук Л.В., Хорева М.В., Варивода А.С. и др. Роль рецепторов врожденного иммунитета в развитии острого инфаркта миокарда //Микробиология. – 2008. – № 4. – С. 64–68.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Boyd J.H., Mathur S., Wang T. et al. Toll-like receptor stimulation in cardiomyocytes decreased contractility and indicates an NF-kB dependent inflammatory response //Cardiovasc. Res. – 2006. – № 72(3). – P. 384–393.</mixed-citation><mixed-citation xml:lang="en">Boyd J.H., Mathur S., Wang T. et al. Toll-like receptor stimulation in cardiomyocytes decreased contractility and indicates an NF-kB dependent inflammatory response //Cardiovasc. Res. – 2006. – № 72(3). – P. 384–393.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu X., Bagchi A., Zhao H. et al. Toll-like receptor 2 activation by bacterial peptidoglycan-associated lipoprotein activates cardiomyocyte inflammation and contractile dysfunction //Crit. Care Med. – 2007. – № 35(3). – P. 886-892.</mixed-citation><mixed-citation xml:lang="en">Zhu X., Bagchi A., Zhao H. et al. Toll-like receptor 2 activation by bacterial peptidoglycan-associated lipoprotein activates cardiomyocyte inflammation and contractile dysfunction //Crit. Care Med. – 2007. – № 35(3). – P. 886-892.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
